• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXECP
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/11/2022
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction photoactivation module leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot l204 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l204 shows no trends.Trends were reviewed for complaint category, photoactivation module leak.No trends were detected for this complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned photographs and smart card data is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).H.M.08 nov 2022.
 
Event Description
The customer contacted mallinckrodt to report they experienced a photoactivation module leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported they observed a leak coming from the photoactivation plate after the treatment was successfully completed.The customer reported the patient was in stable condition.The customer discarded the kit and returned photographs and the smart card data for investigation.
 
Manufacturer Narrative
The customer returned photographs and the smart card data for evaluation.The complaint kit was not returned.A review of the data on the smart card verified the treatment was successfully completed without the occurrence of any alarms, system errors or warnings.The customer provided two photographs for evaluation.The first photograph shows the treatment bag filled with air and a small amount of blood at the bottom.The second photograph shows the inlet and outlet ports of the photoactivation module.Further evaluation of the photograph shows small cracks on the photoactivation module where the inlet and outlet ports are located.During incoming inspection photoactivation plates are sampled and inspected for any obvious damage or defects.No issues were found during incoming inspection for the lots used to manufacture kit lot l204.The reported photoactivation module leak could not be verified based on the photographs provided.A material trace of the photoactivation plates used to build lot l204 did not find any non-conformances.A device history record (dhr) review did not result in any related non-conformances.This lot passed all lot release testing.The customer complaint was not verified based on the available information.No further action is required at this time.This investigation is now complete.Comp-(b)(4).H.M.22 dec 2022.
 
Manufacturer Narrative
The complaint kit was returned for investigation.Examination of the received kit found cracks on the photoactivation module where the inlet and outlet ports are located.The photoactivation module was pressure tested and a leak was verified at the site of the cracks.A known cause for cracks in the photoactivation module is due to excessive solvent used during manufacturing.The solvent can cause damage to the photoactivation module if too much solvent is used and left to set within the plate.The excess solvent is from the bonds that join the tubing and port on the photoactivation module together, causing the plate to crack from the inside out.A material trace of the photoactivation plates used to build lot l204 did not find any non-conformances.A device history record review did not identify any related non-conformances and this kit lot had passed all lot release testing.During incoming inspection photoactivation plates are sampled and inspected for any obvious damage or defects.No issues were found during incoming inspection for the lots used to manufacture kit lot l204.The root cause of the photoactivation module leak is most likely due to excessive solvent during the tube bonding process by the manufacturing operator.Retraining has been completed for the relevant operators to reinforce proper tube bonding instructions.No further action is required at this time.This investigation is now complete.Comp-(b)(4).H.M.17 jul 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
mark wendelken
440 route 22 east
suite 302
bridgewater, NJ 08807
MDR Report Key15751402
MDR Text Key303299161
Report Number3013428851-2022-00079
Device Sequence Number1
Product Code LNR
Combination Product (y/n)Y
Reporter Country CodeFR
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 07/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/01/2024
Device Catalogue NumberCLXECP
Device Lot NumberL204
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/11/2022
Initial Date FDA Received11/08/2022
Supplement Dates Manufacturer Received12/05/2022
06/22/2023
Supplement Dates FDA Received12/22/2022
07/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age71 YR
Patient SexMale
-
-